HRP20120020T1 - Visokoosjetljivi imunoeseji i kompleti za određivanje peptida i proteina od biološkog interesa - Google Patents

Visokoosjetljivi imunoeseji i kompleti za određivanje peptida i proteina od biološkog interesa Download PDF

Info

Publication number
HRP20120020T1
HRP20120020T1 HR20120020T HRP20120020T HRP20120020T1 HR P20120020 T1 HRP20120020 T1 HR P20120020T1 HR 20120020 T HR20120020 T HR 20120020T HR P20120020 T HRP20120020 T HR P20120020T HR P20120020 T1 HRP20120020 T1 HR P20120020T1
Authority
HR
Croatia
Prior art keywords
antibody
glu
kit
val
group
Prior art date
Application number
HR20120020T
Other languages
English (en)
Croatian (hr)
Inventor
Manuel Sarasa Barrio J.
Original Assignee
Araclon Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38544110&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20120020(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Araclon Biotech filed Critical Araclon Biotech
Publication of HRP20120020T1 publication Critical patent/HRP20120020T1/hr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HR20120020T 2007-08-02 2007-12-05 Visokoosjetljivi imunoeseji i kompleti za određivanje peptida i proteina od biološkog interesa HRP20120020T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07380227A EP2020602A1 (en) 2007-08-02 2007-08-02 High sensitivty immunoassays and kits for the determination of peptides and proteins of biological interest
PCT/EP2007/063334 WO2009015696A1 (en) 2007-08-02 2007-12-05 High sensitivty immunoassays and kits for the determination of peptides and proteins of biological interest

Publications (1)

Publication Number Publication Date
HRP20120020T1 true HRP20120020T1 (hr) 2012-03-31

Family

ID=38544110

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20120020T HRP20120020T1 (hr) 2007-08-02 2007-12-05 Visokoosjetljivi imunoeseji i kompleti za određivanje peptida i proteina od biološkog interesa

Country Status (23)

Country Link
US (2) US20090035790A1 (sr)
EP (2) EP2020602A1 (sr)
JP (1) JP5657382B2 (sr)
KR (1) KR101461538B1 (sr)
CN (1) CN101861521B (sr)
AR (1) AR064186A1 (sr)
AT (1) ATE533059T1 (sr)
AU (1) AU2007357025B2 (sr)
BR (1) BRPI0721871A2 (sr)
CA (1) CA2689024C (sr)
CL (1) CL2007003513A1 (sr)
CY (1) CY1112553T1 (sr)
DK (1) DK2183599T3 (sr)
ES (1) ES2377151T3 (sr)
HR (1) HRP20120020T1 (sr)
IL (1) IL202598A (sr)
MX (1) MX2009013009A (sr)
PL (1) PL2183599T3 (sr)
PT (1) PT2183599E (sr)
RS (1) RS52124B (sr)
RU (1) RU2461837C2 (sr)
SI (1) SI2183599T1 (sr)
WO (1) WO2009015696A1 (sr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2478365A1 (en) * 2009-09-18 2012-07-25 Probiodrug AG Novel assay for the detection of amyloid beta peptides
WO2011070174A1 (en) * 2009-12-11 2011-06-16 Araclon Biotech, S.L. Methods and reagents for improved detection of amyloid beta peptides
CN102192985A (zh) * 2010-03-18 2011-09-21 上海依科赛生物制品有限公司 一种人体β淀粉样蛋白试剂盒
KR101352670B1 (ko) * 2010-06-15 2014-01-17 울산대학교 산학협력단 알츠하이머 전구단백질 분비 펩타이드의 축적물을 포함하는 뇌 노화 감별 진단 마커
EP2556378B1 (en) * 2010-07-26 2016-05-18 SNU R & DB Foundation Real-time monitoring of depletion of high-abundance blood proteins or recovery of low-abundance blood proteins by uv spectrometry
WO2012054333A2 (en) * 2010-10-20 2012-04-26 Merck Sharp & Dohme Corp. Methods for identifying inhibitors of abeta42 oligomers
EP2511296A1 (en) * 2011-04-12 2012-10-17 Araclón Biotech, S. L. Antibody, kit and method for determination of amyloid peptides
WO2012149607A1 (en) * 2011-05-03 2012-11-08 Commonwealth Scientific And Industrial Research Organisation Method for detection of a neurological disease
JP6231263B2 (ja) * 2012-07-17 2017-11-15 株式会社島津製作所 アフィニティ支持体及びそれを用いた物質の捕捉方法
JP7434144B2 (ja) * 2018-02-27 2024-02-20 株式会社島津製作所 ＡＰＰ６６９－ｘのＮ末端を特異的に認識する抗体、及び免疫測定法
JP7629278B2 (ja) * 2020-06-25 2025-02-13 シスメックス株式会社 Ａβペプチドを測定するための抗体セット、Ａβペプチドの測定方法及び試薬キット
CN113884683A (zh) * 2020-07-30 2022-01-04 山东京济生物工程有限公司 一种快速检测Aβ42的双抗体夹心ELISA试剂盒
CN114966047A (zh) * 2022-05-10 2022-08-30 上海科华生物工程股份有限公司 一种检测阿尔茨海默病的化学发光试剂盒及其制备方法
CN115932241A (zh) * 2022-12-30 2023-04-07 深圳市天大生物医疗器械有限公司 一种Aβ1-42检测用检测试剂卡及其制备方法与应用
CN118294655A (zh) * 2024-04-12 2024-07-05 上海硅羿生物技术有限公司 一种用于Aβ40/42免疫层析联合定量检测的试剂条及其制备方法
CN118359697A (zh) * 2024-04-29 2024-07-19 上海硅羿生物技术有限公司 β淀粉样蛋白40及β淀粉样蛋白42特异识别多肽及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811310A (en) * 1986-09-30 1998-09-22 Albert Einstein College Of Medicine Of Yeshiva Univ. The Alz-50 monoclonal antibody and diagnostic assay for alzheimer's disease
AU7121191A (en) * 1990-02-26 1991-10-10 Albert Einstein College Of Medicine Of Yeshiva University Diagnostic assay for alzheimer's disease
US7427392B1 (en) * 1994-11-14 2008-09-23 Elan Pharmaceuticals, Inc. Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
US7964192B1 (en) * 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
AU754062B2 (en) * 1998-07-03 2002-10-31 Innogenetics N.V. Differential diagnosis of neurodegeneration
WO2002002769A1 (en) * 2000-07-06 2002-01-10 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw A novel app mutation associated with an unusual alzheimer's disease pathology
EP1371986A1 (en) * 2002-06-06 2003-12-17 ABETA GmbH Diagnosis of Alzheimer's disease based on the hAbeta42:hAbeta40 ratio
PE20050627A1 (es) * 2003-05-30 2005-08-10 Wyeth Corp Anticuerpos humanizados que reconocen el peptido beta amiloideo
NZ562434A (en) * 2005-05-05 2010-04-30 Merck & Co Inc Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease

Also Published As

Publication number Publication date
AU2007357025A1 (en) 2009-02-05
EP2183599B1 (en) 2011-11-09
RU2461837C2 (ru) 2012-09-20
US20090035790A1 (en) 2009-02-05
SI2183599T1 (sl) 2012-03-30
CN101861521A (zh) 2010-10-13
DK2183599T3 (da) 2012-02-27
IL202598A (en) 2015-10-29
RU2009143671A (ru) 2011-05-27
CA2689024A1 (en) 2009-02-05
RS52124B (sr) 2012-08-31
CN101861521B (zh) 2014-03-12
ATE533059T1 (de) 2011-11-15
PT2183599E (pt) 2012-02-13
PL2183599T3 (pl) 2012-04-30
MX2009013009A (es) 2010-03-29
JP5657382B2 (ja) 2015-01-21
WO2009015696A1 (en) 2009-02-05
IL202598A0 (en) 2010-06-30
KR20100046168A (ko) 2010-05-06
BRPI0721871A2 (pt) 2014-02-18
AR064186A1 (es) 2009-03-18
EP2183599A1 (en) 2010-05-12
US20190178899A1 (en) 2019-06-13
ES2377151T3 (es) 2012-03-22
CY1112553T1 (el) 2016-02-10
EP2020602A1 (en) 2009-02-04
CL2007003513A1 (es) 2009-02-06
JP2010535328A (ja) 2010-11-18
KR101461538B1 (ko) 2014-11-14
CA2689024C (en) 2015-02-24
AU2007357025B2 (en) 2014-10-23

Similar Documents

Publication Publication Date Title
HRP20120020T1 (hr) Visokoosjetljivi imunoeseji i kompleti za određivanje peptida i proteina od biološkog interesa
Selo et al. Preferential labeling of α-amino N-terminal groups in peptides by biotin: application to the detection of specific anti-peptide antibodies by enzyme immunoassays
JP6734258B2 (ja) オキシトシンの高感度測定法
CN103969447A (zh) 用于血管内皮生长因子定量测定试剂盒及其发光底物溶液
ES2323271T3 (es) Metodo de pretratamiento de una muestra y metodo de dosificacion inmunologica utilizado.
Chiari et al. Peptide microarrays for the characterization of antigenic regions of human chromogranin A
CN111051889B (zh) 检测癌症的方法和检测试剂
CN113832132B (zh) 一种烙铁头svmp蛋白特异性短肽、抗烙铁头svmp蛋白抗体和蛇伤检测试剂盒
CN113727995A (zh) 检测癌的方法和检测试剂
US7094551B2 (en) Immunoassays, assay methods, antibodies and method of creating antibodies for detecting FGF-23
Grassi et al. Two different approaches for developing immunometric assays of haptens
Fierabracci et al. Osteopontin is an autoantigen of the somatostatin cells in human islets: identification by screening random peptide libraries with sera of patients with insulin-dependent diabetes mellitus
CN111656196A (zh) 肾癌的检测方法和检查试剂
WO2013000568A1 (en) Method of obtaining a binder to prepro-vasopressin or fragments thereof
CN107406515B (zh) 合成的双表位化合物
JP2016114573A (ja) オキシトシン検出のためのサンプルの前処理方法
CN109293762A (zh) DRC3f抗原多肽，抗DRC3f的多克隆抗体及应用
CN108956996A (zh) 检测人st2蛋白的荧光免疫层析试纸及其制备方法
JP2744001B2 (ja) 膵臓チモーゲンの遊離活性化ペプチドの免疫分析による診断、厳密な予測および監視
US20210261690A9 (en) Method of Generating Anti-Linaclotide Antibodies and Uses Thereof
Rehfeld et al. Measurement of cholecystokinin in biological fluids
CN113930408B (zh) 一种竹叶青pla2蛋白特异性短肽、抗竹叶青pla2蛋白抗体和蛇伤检测试剂盒
US20250130242A1 (en) Immunological detection method and immunological detection kit
CN103848898B (zh) 双酚A的抗原模拟表位Ph3及其应用
US20250155453A1 (en) Immunological detection method and immunological detection kit